EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI HUNGARY Ltd. Budapest HU
02 1EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION Taipei TW
01 2Alprostadil
01 1France
02 1Taiwan
01 2Valid
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Certificate Number : R1-CEP 2015-302 - Rev 00
Status : Valid
Issue Date : 2022-01-31
Type : Chemical
Substance Number : 1488
Certificate Number : CEP 2012-204 - Rev 02
Status : Valid
Issue Date : 2025-10-28
Type : Chemical
Substance Number : 1488
38
PharmaCompass offers a list of Alprostadil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alprostadil manufacturer or Alprostadil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alprostadil manufacturer or Alprostadil supplier.
PharmaCompass also assists you with knowing the Alprostadil API Price utilized in the formulation of products. Alprostadil API Price is not always fixed or binding as the Alprostadil Price is obtained through a variety of data sources. The Alprostadil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid, including repackagers and relabelers. The FDA regulates (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid supplier is an individual or a company that provides (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid active pharmaceutical ingredient (API) or (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid finished formulations upon request. The (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid suppliers may include (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid API manufacturers, exporters, distributors and traders.
click here to find a list of (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP of the European Pharmacopoeia monograph is often referred to as a (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid Certificate of Suitability (COS). The purpose of a (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid to their clients by showing that a (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP has been issued for it. The manufacturer submits a (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP holder for the record. Additionally, the data presented in the (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid DMF.
A (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid suppliers with CEP (COS) on PharmaCompass.
We have 2 companies offering (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid
Get in contact with the supplier of your choice:
